Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for NBIX

Stock NameNeurocrine Biosciences Inc
TickerNBIX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS64125C1099
LEI549300FECER0XBN49756

Show aggregate NBIX holdings

News associated with NBIX

Sum Up The Parts: SCHG Could Be Worth $34
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-21 10:23:31
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Maryland State Retirement & Pension System
Maryland State Retirement & Pension System lowered its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 12.5% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,661 shares of the company’s stock after selling 663 shares during the quarter. Maryland […] - 2025-08-15 05:24:56
Charles Schwab Investment Management Inc. Purchases 13,216 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Charles Schwab Investment Management Inc. raised its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 775,773 shares of the company’s stock after acquiring an additional 13,216 shares during the quarter. Charles […] - 2025-08-13 05:10:46
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Blair William & Co. IL
Blair William & Co. IL cut its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 3.7% in the first quarter, Holdings Channel reports. The fund owned 6,214 shares of the company’s stock after selling 242 shares during the period. Blair William & Co. IL’s holdings in Neurocrine Biosciences were worth $687,000 at the […] - 2025-08-11 05:52:52
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Federated Hermes Inc.
Federated Hermes Inc. trimmed its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 72.9% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 9,441 shares of the company’s stock after selling 25,402 shares during the quarter. Federated Hermes Inc.’s […] - 2025-08-07 05:22:58
Natixis Advisors LLC Sells 292 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Natixis Advisors LLC lowered its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 0.9% in the first quarter, Holdings Channel.com reports. The institutional investor owned 33,312 shares of the company’s stock after selling 292 shares during the period. Natixis Advisors LLC’s holdings in Neurocrine Biosciences were worth $3,684,000 at the end of the […] - 2025-08-07 04:49:07
Neurocrine (NBIX) Q2 2025 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo - 2025-08-05 01:16:10
Neurocrine (NBIX) Q2 Revenue Jumps 17%
Key PointsNon-GAAP earnings per share of $1.65 for Q2 2025 vastly exceeded the analyst estimate of $0.96. - 2025-08-01 01:15:16
13,202 Shares in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Bought by Y Intercept Hong Kong Ltd
Y Intercept Hong Kong Ltd acquired a new position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund acquired 13,202 shares of the company’s stock, valued at approximately $1,460,000. Other hedge funds and other institutional investors have also recently bought and sold shares of the company. […] - 2025-07-24 06:50:57
HighPoint Advisor Group LLC Purchases 366 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
HighPoint Advisor Group LLC boosted its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 15.0% during the first quarter, Holdings Channel.com reports. The fund owned 2,812 shares of the company’s stock after acquiring an additional 366 shares during the quarter. HighPoint Advisor Group LLC’s holdings in Neurocrine Biosciences were worth $302,000 […] - 2025-07-24 05:51:14
Neurocrine Biosciences (NASDAQ:NBIX) Now Covered by Analysts at Truist Financial
Truist Financial initiated coverage on shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) in a research report report published on Monday, Marketbeat reports. The firm issued a buy rating and a $163.00 price target on the stock. NBIX has been the subject of several other reports. Royal Bank Of Canada reaffirmed an “outperform” rating and […] - 2025-07-22 04:28:48
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Position Trimmed by Cerity Partners LLC
Cerity Partners LLC decreased its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 20.1% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 33,361 shares of the company’s stock after selling 8,376 shares during the quarter. Cerity Partners LLC’s holdings in […] - 2025-07-18 04:55:08
Ingrid Delaet Sells 457 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) insider Ingrid Delaet sold 457 shares of the business’s stock in a transaction on Thursday, July 10th. The stock was sold at an average price of $135.00, for a total transaction of $61,695.00. Following the completion of the transaction, the insider directly owned 4,730 shares in the […] - 2025-07-14 07:16:47
Bank of New York Mellon Corp Has $91.65 Million Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Bank of New York Mellon Corp lessened its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 4.8% during the first quarter, HoldingsChannel reports. The fund owned 828,682 shares of the company’s stock after selling 41,608 shares during the quarter. Bank of New York Mellon Corp’s holdings in Neurocrine Biosciences were worth $91,652,000 as […] - 2025-07-11 05:40:57
Principal Financial Group Inc. Has $27.48 Million Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Principal Financial Group Inc. reduced its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.6% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 248,420 shares of the company’s stock after selling 4,049 shares during the period. Principal Financial Group Inc. owned 0.25% of Neurocrine Biosciences […] - 2025-07-09 05:51:40
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Recommendation of “Moderate Buy” by Analysts
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-two brokerages that are presently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and nineteen have given a buy recommendation to the company. The average 12 […] - 2025-07-09 03:09:50
First Horizon Advisors Inc. Has $43,000 Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
First Horizon Advisors Inc. decreased its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 55.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 385 shares of the company’s stock after selling 480 shares during the quarter. First Horizon Advisors […] - 2025-07-08 05:49:06
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Insider Jude Onyia Sells 20,362 Shares
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) insider Jude Onyia sold 20,362 shares of the company’s stock in a transaction on Wednesday, July 2nd. The stock was sold at an average price of $130.13, for a total value of $2,649,707.06. Following the completion of the sale, the insider owned 18,289 shares of the company’s […] - 2025-07-08 05:06:50
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by KBC Group NV
KBC Group NV lessened its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 3.5% in the 1st quarter, Holdings Channel reports. The fund owned 13,835 shares of the company’s stock after selling 495 shares during the period. KBC Group NV’s holdings in Neurocrine Biosciences were worth $1,530,000 as of its most recent filing […] - 2025-07-04 06:58:45
New York State Teachers Retirement System Lowers Stock Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
New York State Teachers Retirement System lowered its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.9% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 108,481 shares of the company’s stock after selling 2,055 shares during the quarter. New York State Teachers Retirement System’s holdings in Neurocrine Biosciences were worth $11,998,000 […] - 2025-07-04 06:14:58
Amalgamated Bank Has $5.28 Million Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Amalgamated Bank lessened its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 3.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 47,719 shares of the company’s stock after selling 1,895 shares during the quarter. Amalgamated Bank’s holdings in Neurocrine Biosciences were […] - 2025-07-03 06:14:49
Sumitomo Mitsui Trust Group Inc. Sells 1,399 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Sumitomo Mitsui Trust Group Inc. reduced its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 0.6% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 231,458 shares of the company’s stock after selling 1,399 shares during the quarter. Sumitomo Mitsui Trust […] - 2025-07-03 05:35:01
Golden State Wealth Management LLC Grows Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Golden State Wealth Management LLC increased its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 116.9% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 397 shares of the company’s stock after purchasing an additional 214 shares during the quarter. […] - 2025-07-02 05:01:01
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Acquired by Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc. raised its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 2.4% in the 1st quarter, HoldingsChannel.com reports. The fund owned 19,388 shares of the company’s stock after buying an additional 447 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Neurocrine Biosciences were worth $2,144,000 as […] - 2025-06-27 05:10:49
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Retirement Systems of Alabama
Retirement Systems of Alabama cut its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.4% in the 1st quarter, Holdings Channel reports. The firm owned 121,352 shares of the company’s stock after selling 1,755 shares during the period. Retirement Systems of Alabama’s holdings in Neurocrine Biosciences were worth $13,422,000 at the […] - 2025-06-23 05:04:51
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Bought by QRG Capital Management Inc.
QRG Capital Management Inc. lifted its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 7.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 20,062 shares of the company’s stock after buying an additional 1,330 shares […] - 2025-06-20 06:54:59
Sowell Financial Services LLC Takes Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Sowell Financial Services LLC bought a new stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 4,786 shares of the company’s stock, valued at approximately $529,000. Other institutional investors and hedge funds […] - 2025-06-20 05:29:06
Trust Point Inc. Sells 660 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Trust Point Inc. decreased its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 26.6% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,823 shares of the company’s stock after selling 660 shares during the period. Trust Point Inc.’s holdings in […] - 2025-06-19 05:35:02
XBI, EXAS, NBIX, NTRA: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $443.9 million dollar outflow -- that's a 8.8% decrease week over week - 2025-06-17 11:54:37
Merit Financial Group LLC Acquires 345 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Merit Financial Group LLC raised its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 9.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,153 shares of the company’s stock after purchasing an additional 345 shares during the quarter. Merit Financial Group […] - 2025-06-11 05:00:51

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) NBIX holdings

DateNumber of NBIX Shares HeldBase Market Value of NBIX SharesLocal Market Value of NBIX SharesChange in NBIX Shares HeldChange in NBIX Base ValueCurrent Price per NBIX Share HeldPrevious Price per NBIX Share Held
2025-11-11 (Tuesday)64,382USD 9,482,825USD 9,482,825
2025-11-10 (Monday)64,382NBIX holding increased by 164USD 9,658,588NBIX holding decreased by -126309USD 9,658,588164USD -126,309 USD 150.02 USD 152.37
2025-11-07 (Friday)64,218USD 9,784,897NBIX holding decreased by -156049USD 9,784,8970USD -156,049 USD 152.37 USD 154.8
2025-11-06 (Thursday)64,218NBIX holding increased by 164USD 9,940,946NBIX holding increased by 92643USD 9,940,946164USD 92,643 USD 154.8 USD 153.75
2025-11-05 (Wednesday)64,054USD 9,848,303NBIX holding increased by 676411USD 9,848,3030USD 676,411 USD 153.75 USD 143.19
2025-11-04 (Tuesday)64,054NBIX holding increased by 165USD 9,171,892NBIX holding increased by 102210USD 9,171,892165USD 102,210 USD 143.19 USD 141.96
2025-11-03 (Monday)63,889USD 9,069,682NBIX holding decreased by -79862USD 9,069,6820USD -79,862 USD 141.96 USD 143.21
2025-10-31 (Friday)63,889USD 9,149,544NBIX holding increased by 330306USD 9,149,5440USD 330,306 USD 143.21 USD 138.04
2025-10-30 (Thursday)63,889NBIX holding increased by 825USD 8,819,238NBIX holding increased by 115145USD 8,819,238825USD 115,145 USD 138.04 USD 138.02
2025-10-29 (Wednesday)63,064NBIX holding increased by 575USD 8,704,093NBIX holding decreased by -505536USD 8,704,093575USD -505,536 USD 138.02 USD 147.38
2025-10-28 (Tuesday)62,489USD 9,209,629NBIX holding decreased by -97483USD 9,209,6290USD -97,483 USD 147.38 USD 148.94
2025-10-27 (Monday)62,489USD 9,307,112NBIX holding increased by 308696USD 9,307,1120USD 308,696 USD 148.94 USD 144
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of NBIX by Blackrock for IE00BYXG2H39

Show aggregate share trades of NBIX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY164154.100146.020 146.828USD 24,080 125.08
2025-11-06BUY164155.640152.860 153.138USD 25,115 124.80
2025-11-04BUY165143.870140.820 141.125USD 23,286 124.56
2025-10-30BUY825140.190136.510 136.878USD 112,924 124.31
2025-10-29BUY575138.020144.240 143.618USD 82,580 124.24
2025-10-22SELL-660141.470143.690 143.468USD -94,689 123.69 Loss of -13,052 on sale
2025-10-20BUY330141.330142.590 142.464USD 47,013 123.50
2025-10-17BUY824140.090140.470 140.432USD 115,716 123.41
2025-10-15BUY1,312137.730139.460 139.287USD 182,745 123.33
2025-10-03BUY1,141137.030137.800 137.723USD 157,142 123.18
2025-10-02BUY163136.740137.630 137.541USD 22,419 123.11
2025-09-30BUY326140.380141.690 141.559USD 46,148 122.94
2025-09-26BUY326142.000142.080 142.072USD 46,315 122.74
2025-09-25BUY326140.890145.610 145.138USD 47,315 122.64
2025-09-24SELL-2,672146.670148.000 147.867USD -395,101 122.50 Loss of -67,778 on sale
2025-09-18BUY170145.660146.030 145.993USD 24,819 122.37
2025-09-17BUY513142.730143.390 143.324USD 73,525 122.25
2025-09-11SELL-171143.600143.820 143.798USD -24,589 122.02 Loss of -3,723 on sale
2025-09-10BUY342141.250145.160 144.769USD 49,511 121.91
2025-09-05SELL-171144.100145.790 145.621USD -24,901 121.52 Loss of -4,121 on sale
2025-08-20SELL-684133.230133.710 133.662USD -91,425 121.26 Loss of -8,481 on sale
2025-08-18BUY342133.140133.540 133.500USD 45,657 121.12
2025-07-30BUY684136.760137.120 137.084USD 93,765 120.80
2025-07-17SELL-342134.110135.700 135.541USD -46,355 120.08 Loss of -5,288 on sale
2025-07-16BUY594133.480134.250 134.173USD 79,699 119.99
2025-07-11SELL-1,352133.460135.000 134.846USD -182,312 119.72 Loss of -20,452 on sale
2025-07-07BUY507127.880129.070 128.951USD 65,378 119.40
2025-07-02BUY9,295129.400130.420 130.318USD 1,211,306 119.26
2025-06-20BUY1,084126.550128.380 128.197USD 138,966 119.20
2025-06-11BUY330124.170125.510 125.376USD 41,374 118.88
2025-06-10BUY330124.770127.510 127.236USD 41,988 118.83
2025-06-04SELL-165124.520125.990 125.843USD -20,764 118.64 Loss of -1,189 on sale
2025-04-23BUY165103.220106.200 105.902USD 17,474 119.22
2025-04-10SELL-1,32090.72094.250 93.897USD -123,944 121.41 Profit of 36,319 on sale
2025-04-08SELL-16587.54096.000 95.154USD -15,700 122.10 Profit of 4,446 on sale
2025-04-07SELL-16593.25096.440 96.121USD -15,860 122.44 Profit of 4,342 on sale
2025-04-04SELL-82595.650100.520 100.033USD -82,527 122.75 Profit of 18,743 on sale
2025-04-01BUY1,433107.000110.890 110.501USD 158,348 123.12
2025-03-31SELL-489110.600112.600 112.400USD -54,964 123.27 Profit of 5,314 on sale
2025-03-21BUY1,238111.920112.530 112.469USD 139,237 123.98
2025-03-14SELL-2,544110.750111.270 111.218USD -282,939 124.93 Profit of 34,894 on sale
2025-03-07SELL-318113.040115.000 114.804USD -36,508 126.08 Profit of 3,585 on sale
2025-03-04SELL-159113.110114.390 114.262USD -18,168 126.69 Profit of 1,976 on sale
2025-02-25BUY318115.900120.000 119.590USD 38,030 127.54
2025-02-19SELL-159114.260114.930 114.863USD -18,263 128.28 Profit of 2,133 on sale
2025-02-13BUY477116.870118.610 118.436USD 56,494 129.33
2025-02-12BUY159117.180118.010 117.927USD 18,750 129.57
2025-02-11BUY636116.850116.940 116.931USD 74,368 129.84
2025-01-02BUY175137.860139.470 139.309USD 24,379 123.46
2024-12-30SELL-5,480137.060138.650 138.491USD -758,931 123.05 Loss of -84,613 on sale
2024-11-18SELL-2,595117.620118.320 118.250USD -306,859 120.21 Profit of 5,080 on sale
2024-11-08SELL-173125.740126.280 126.226USD -21,837 119.33 Loss of -1,194 on sale
2024-10-21SELL-173116.570117.890 117.758USD -20,372 0.00 Loss of -20,372 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of NBIX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19138,3040280,71449.3%
2025-09-18207,77644,506326,19463.7%
2025-09-17106,323343194,59754.6%
2025-09-1697,81119,146256,98038.1%
2025-09-1573,3630197,45737.2%
2025-09-1271,8171,305193,96837.0%
2025-09-1187,2040250,36934.8%
2025-09-10117,0990288,60540.6%
2025-09-09123,3791,879226,94154.4%
2025-09-08213,6691,667350,78760.9%
2025-09-05269,8828,988447,93060.3%
2025-09-04193,322481275,12970.3%
2025-09-03210,597108556,90537.8%
2025-09-02183,31915,512318,15057.6%
2025-08-29101,0617,590154,07965.6%
2025-08-28127,383487193,56165.8%
2025-08-27137,4541,818217,03363.3%
2025-08-26170,0223,558291,09658.4%
2025-08-25124,1533,639195,47663.5%
2025-08-22126,62910,885196,28864.5%
2025-08-21119,2451,265200,99059.3%
2025-08-20135,1384,637230,01058.8%
2025-08-19186,010535287,33064.7%
2025-08-18162,0387,351232,60969.7%
2025-08-15140,024100220,19963.6%
2025-08-14290,907253363,13980.1%
2025-08-13356,4048,730466,19176.5%
2025-08-12303,9754,067434,64169.9%
2025-08-11279,1915,617413,02767.6%
2025-08-08338,3850490,22069.0%
2025-08-07341,7192486,06070.3%
2025-08-06162,49452290,74155.9%
2025-08-05127,812122285,40144.8%
2025-08-04184,650798554,60133.3%
2025-08-01384,652274613,13762.7%
2025-07-31795,02721,403,51956.6%
2025-07-30277,359199566,94248.9%
2025-07-29235,4831,232479,50449.1%
2025-07-28128,7961,272304,76342.3%
2025-07-25164,9590533,68230.9%
2025-07-24143,137442360,99139.7%
2025-07-23127,087250336,56737.8%
2025-07-22110,378700199,61455.3%
2025-07-2194,76891171,48155.3%
2025-07-18136,185216238,83657.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.